Enrolling Clinical Research Studies

Celiac Disease on a Gluten Free Diet

Chronic Obstructive Pulmonary Disease (COPD)

Contraceptive Study

DIRECT TRANSMISSION OF INFLUENZA FROM OTHERWISE HEALTHY PATIENTS

Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Mod

Gastroparesis

PREMENOPAUSAL PATIENTS WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (FLU)

Treatment Trial for Outpatients with COVID-19

Uncontrolled Asthma

Urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infect

Uterine Fibroids or Endometriosis women who are at Risk for Pregn

Future Studies
Upcoming Studies for Men & Women

Upcoming Studies for Men & Women

Click to add your name to the waiting list for upcoming studies. We will alert you when we begin a new study. Please provide your email address if possible.

*PLEASE DO NOT CALL THE STUDY CENTER UNLESS YOU ARE CONTACTED FIRST*

» Study Details | Apply for the Study

Gastroenterology
Celiac Disease on a Gluten Free Diet

Celiac Disease on a Gluten Free Diet

If you are experiencing celiac disease symptoms despite following a gluten-free diet, you may want to talk to your doctor about our clinical study.

» Study Details | Apply for the Study

Patients with Gastroparesis

Patients with Gastroparesis

Safety and Efficacy of NG101 Administered Orally to Patients with Gastroparesis

» Study Details | Apply for the Study

 Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohn's Disease

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)

» Study Details | Apply for the Study

Pulmonary
Patients with moderate-to-severe chronic obstructive pulmonary disease (COP

Patients with moderate-to-severe chronic obstructive pulmonary disease (COP

Phase 3 study to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti- IL-33 mAb) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD)

» Study Details | Apply for the Study

Women’s Health
PREMENOPAUSAL PATIENTS WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)

PREMENOPAUSAL PATIENTS WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)

MULTI-CENTER, MULTIPLE-DOSE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SILDENAFIL CREAM, 3.6% IN PREMENOPAUSAL PATIENTS WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)

» Study Details | Apply for the Study

Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

» Study Details | Apply for the Study

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are at Risk for Pregnancy

» Study Details | Apply for the Study

Allergy & Asthma
Severe uncontrolled asthma with an eosinophilic phenotype

Severe uncontrolled asthma with an eosinophilic phenotype

Severe Uncontrolled Asthma With An Eosinophilic Phenotype

» Study Details | Apply for the Study

ID
Phase 3 double-blind placebo-controlled efficacy tPrevention of urogenital

Phase 3 double-blind placebo-controlled efficacy tPrevention of urogenital

Vaginal gel for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection

» Study Details | Apply for the Study

Adaptive Platform Treatment Trial for Outpatients with COVID-19

Adaptive Platform Treatment Trial for Outpatients with COVID-19

Adaptive Platform Treatment Trial for Outpatients with COVID-19

» Study Details | Apply for the Study

 

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS

A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF NORKETOTIFEN IN THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (ILI)

» Study Details | Apply for the Study

DIRECT TRANSMISSION OF INFLUENZA FROM OTHERWISE HEALTHY PATIENTS

DIRECT TRANSMISSION OF INFLUENZA FROM OTHERWISE HEALTHY PATIENTS

DIRECT TRANSMISSION OF INFLUENZA FROM OTHERWISE HEALTHY PATIENTS TO HOUSEHOLD CONTACTS

» Study Details | Apply for the Study

Powered By RealTime-CTMS Clinical Trial Management System